Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tektin-3 (TEKT3) is a member of the tektin family of filamentous proteins, enriched in male germ cells and localized predominantly to the axoneme and peri-axonemal structures of sperm flagella and cilia[1][2][3][4]. TEKT3 is coassembled with tubulins to form stable components of ciliary and flagellar microtubules, contributing to the structural integrity and motility of these organelles[1][4]. In mammals, TEKT3 is crucial for maintaining normal progressive sperm motility, and loss of TEKT3 in mice impairs sperm movement and causes characteristic flagellar bending defects, though fertile male reproduction is often preserved[1]. Humans with TEKT3 mutations have been linked to specific forms of male infertility, notably spermatogenic failure 81 and asthenozoospermia[2][3][4]. TEKT3 is typically not considered a classical druggable therapeutic target (like a receptor, enzyme, or ion channel), but is important as a candidate gene in the genetic diagnosis of male infertility[1][2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tektin-3 (TEKT3).